GanirelixHormone TherapySafety Rating 9/10

Primary research areaIVF protocol

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range0.25 mg daily SC
AdministrationSubcutaneous injection
Safety9/10 · FDA-approved
NCAA D1Banned

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Overview

About Ganirelix

Mechanism of action

GnRH receptor antagonist; rapid competitive inhibition of GnRH receptors

Safety profile

Injection site reactions, nausea, abdominal pain · Widely used in IVF; well-characterized; injection site reactions; headache

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Ganirelix

Failed to fetch